ORGANON & CO.

Lobbying for ORGANON & CO.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $280,000.00 expenses · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (PL 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing

Budget/Appropriations

FY26 appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.